Document Detail


Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.
MedLine Citation:
PMID:  6969985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of nifedipine, a potent calcium antagonist, were studied in patients with unstable angina, coronary spasm and myocardial ischemia. Data from two separate groups of patients studied in the cardiac catheterization laboratory indicate that intracoronary injection of nifedipine promptly reversed coronary spasm--whether provoked or spontaneous--in five of six patients. In other patients, direct intracoronary injection of the drug was compared with intravenous administration. After intracoronary injection, local mechanical cardiac action virtually ceased, and the ventricular wall became thinner during systole. Thus, a specific inhibitory action on contractile energy expenditure could be demonstrated in the presence of increased coronary flow. This "oxygen-sparing" effect was tested in a group of 31 patients with symptomatic unstable angina whose pain at rest, with ST-T changes, had not responded to 8 hours of treatment with maximal beta adrenergic blockade, nitrates and bed rest. The addition of 6 X 10 mg of nifedipine rendered 27 of these patients asymptomatic within 1.5 hours. In the four patients who did not respond, coronary arteriography demonstrated severely stenotic lesions. Two of the four patients subsequently responded to intraaortic balloon pumping and bypass surgery; one patient had a myocardial infarction and one who had a 90 percent reduction in the diameter of the left main coronary artery, died. It is concluded that nifedipine should be added to beta adrenergic blockade therapy if the latter does not appear to be immediately effective. This combination has not been shown to cause any hemodynamic deterioration, and only a minority of the patients treated sustained a myocardial infarction during the first 3 months of follow-up. The use of nifedipine in unstable angina deserves further clinical evaluation.
Authors:
P G Hugenholtz; H R Michels; P W Serruys; R W Brower
Related Documents :
10608025 - Optimizing the treatment of unstable angina.
18388075 - Progression of nonculprit plaque stenosis following successful percutaneous intervention.
20859545 - Recent advances in the management of chronic stable angina ii. anti-ischemic therapy, o...
21119525 - Huge coronary perforation during percutaneous intervention sealed by injection of polyv...
1953615 - Response of coronary arteries to nitrates, the edrf-donor sin-1, and calcium antagonists.
7858785 - Discrimination of ventricular tachycardia from sinus tachycardia by antitachycardia dev...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  47     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1981 Jan 
Date Detail:
Created Date:  1981-03-17     Completed Date:  1981-03-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  163-73     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Angina Pectoris / complications,  drug therapy*
Angina Pectoris, Variant / drug therapy*
Coronary Angiography
Coronary Artery Bypass
Coronary Disease / drug therapy*
Female
Heart Catheterization
Humans
Male
Middle Aged
Myocardial Infarction / complications
Nifedipine / therapeutic use*
Pyridines / therapeutic use*
Chemical
Reg. No./Substance:
0/Pyridines; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ventricular aneurysm: cross-sectional echocardiographic approach.
Next Document:  Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.